Covington

A leading legal practice, built at the intersection of law and policy. That’s what makes Covington different: okt.to/RfLJ1V

How has the landscape for recognising and enforcing foreign judgments in #England and #Wales evolved since #Brexit? Find out with @CovingtonLLP in the ICLG #Enforcement of #ForeignJudgments 2026➡️: obi41.nl/4jw3z55r

Read our new post: Covington Announces Political Law Survey (2026 Edition) okt.to/J2FkgM

Read our new post: Covington Announces Pay-to-Play Survey (2026 Edition) okt.to/TJM97d

Read our new post - The Paper Trail Starts Now: Minority Document Preservation Letters and Preparing for Oversight to Come okt.to/lVbsGa

This alert summarizes publicly available FDA enforcement letters relating to the advertising and promotion of prescription drugs, medical devices, and biologics, sent in 2025: okt.to/3MFV1h

Read our new post: Covington Releases Updated Version of “FARA: A Guide for the Perplexed” okt.to/ivxEfZ

The U.S. Attorney’s Office for the Southern District of New York has announced a new “Corporate Enforcement and Voluntary Self-Disclosure Program for Financial Crimes.” In this alert, we analyze the Program’s potential benefits and risks for companies: okt.to/ykNuFd

In the last 12 months, the world has witnessed global developments and technological change that could hardly have been predicted. To help you navigate this evolving landscape, our ‘Exposures Explained’ guide discusses five key emerging coverage risks: okt.to/uXW70v

Congratulations to our Project Development and Finance team, who has been recognized at the PFI Awards 2025 for their work on landmark transactions around the world. Read more: okt.to/S1gnlX

Read our new post: Senator Grassley Introduces Legislation Requiring Disclosure of Foreign Third‑Party Litigation Funding okt.to/aWr0wN

Read our new post: A Potentially Overlooked Risk Area: Incorporating Congressional Investigations into Transactional Due Diligence okt.to/Q1qIkS

Constricted access to very critical minerals, including heavy rare earth elements, is a specific policy challenge that likely requires nuanced solutions distinct in some ways from general critical minerals supply chain strategies. Find out more: okt.to/dW5DsB

Join Amy Leiser of @CovingtonLLP, Don Horton of @labcorp and @LaurenRSilvis of @TempusLabs to explore the regulatory landscape for clinical labs after the ACLA v. FDA decision at the #ACLA2026 Annual Meeting. Register here: bit.ly/458rvPv.

We are Covington in London: More than 120 lawyers provide our clients with practical advice in an increasingly regulated world. okt.to/2k5Jyz

Read our new post: Election Recounts and Disputes okt.to/Gk0CIM

Read our new post: Democratic Investigations Agenda is Coming Into Focus okt.to/VY3HXa

This alert provides a summary of publicly available FDA enforcement letters relating to the advertising and promotion of prescription drugs, medical devices, and biologics, for the fourth quarter of 2025: okt.to/nOgSHE

Earlier this month, the U.S. Consumer Product Safety Commission hosted a webinar to prepare importers, brokers, and trade partners for the transition to mandatory electronic filing of data from product certificates of compliance. Read the key takeaways: okt.to/o46Slj

In this alert, we discuss the key issues arising from recent developments in Venezuela, and their implications for businesses: okt.to/6oXqdL